Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
Ontology highlight
ABSTRACT: Following publication of the original article [1], based on the authors review, the GLP1 receptor agonists in type 2 diabetes published in Cardiovascular Diabetology, a meta-analysis of GLP-1 and non-GLP-1 based therapies was performed on cardiovascular outcomes.
SUBMITTER: Sposito AC
PROVIDER: S-EPMC6396451 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA